, and is listed on the TSX Venture Exchange (TSX.V:ABV). AlgaeBio owns and operates large-scale production facilities near Holbrook, Ariz. With access to near-perfect algae growing conditions, exclusive aquaculture access to a pristine brine water supply, and advanced proprietary technology, AlgaeBio produces superior human and animal consumable products, as well as offering advanced algae-based products and technologies for distribution into the agribusiness, biofuel, and aquaculture markets. The company's acknowledged expertise is in the maintenance of healthy digestive processes GHT markets and sells a distinctive line of health products, including probiotics, enzymes, antioxidants, and other important nutraceuticals, that focus on the digestive system.ĪBOUT ALGAE BIOSCIENCES CORPORATION: AlgaeBio is a Canadian biotechnology company that researches, develops, and manufactures ultra-pure products from micro and macro algae such as nutraceuticals, food additives, and pharmaceuticals. Global Health Trax, established in 1996, is an industry leader in nutraceutical formulation and distribution on a worldwide basis. The vast majority of competing products on the market contain one or the other, usually DHA, and many are purity challenged. ![]() The first order of business will be ramping up to large-scale commercial production of ultra-pure, algae-based omega-3 fatty acid oils by early 2012.ĪlgaeBio's omega-3 products contain both EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), essential long-chain fatty acids that provide a wide range of health benefits. "This contract will help to establish AlgaeBio's worldwide reach with a wide variety of core and supplemental products."ĪlgaeBio, a Canadian public biotechnology company, announced in mid-August a $5-million, first-phase expansion of its production facilities near Holbrook, Ariz. "GHT has developed global channels of distribution," notes AlgaeBio Chairman Robert J. The contract gives Global Health Trax, based in Vista, Calif., exclusive rights to purchase and distribute AlgaeBio's ultra-pure omega-3 products destined for the nutraceutical, food additive, and animal feed markets. ![]() Vancouver, British Columbia-(October 13, 2011) - Algae Biosciences Corporation (TSXV: ABV) is pleased to confirm that it has a comprehensive purchase and distribution contract in place with Global Health Trax ("GHT") regarding AlgaeBio's algae-based, omega-3 products. Company Overview Our Team Our Commitment Success Stories Upcoming Events CareersĪlgaeBio Announces Omega-3 Distribution Contract with Global Health Trax.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |